Regnum Corp. Stock Other OTC
Equities
RGMP
US75915R1068
Biotechnology & Medical Research
Sales 2021 | - | Sales 2022 | - | Capitalization | 3.1M 4.23M |
---|---|---|---|---|---|
Net income 2021 | - 0 | Net income 2022 | - 0 | EV / Sales 2021 | - |
Net Debt 2021 | 22.06K 30.12K | Net Debt 2022 | 773K 1.05M | EV / Sales 2022 | - |
P/E ratio 2021 |
-13
x | P/E ratio 2022 |
-3.97
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 1.18% |
1st Jan change | Capi. | |
---|---|---|
+2.39% | 42.75B | |
+47.70% | 41.61B | |
+11.98% | 41.34B | |
-8.83% | 26.59B | |
+7.16% | 25.49B | |
-22.67% | 18.12B | |
+30.83% | 12.24B | |
-2.06% | 11.76B | |
+9.31% | 11B |